Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Travoprost

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Travatan Alcon

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,635,350Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Approves Alembic's Travoprost Ophthalmic Solution USP
    FDA Approves Alembic's Travoprost Ophthalmic Solution USP

    22 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/alembic-announces-usfda-final-approval-for-travoprost-ophthalmic-solution-usp-0004-18621

    INDPHARMAPOST
    22 Dec 2025
    Share Share
    USFDA Approves Alembic's 0.004% Travoprost Solution
    USFDA Approves Alembic's 0.004% Travoprost Solution

    18 Dec 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/alembic-pharmaceuticals-gets-usfda-final-approval-for-travoprost-ophthalmic-solution-usp-0-004/

    EXPRESSPHARMA
    18 Dec 2025
    Share Share
    Alembic’s Generics Travoprost Receives Approval in US
    Alembic’s Generics Travoprost Receives Approval in US

    17 Dec 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214687

    FDA
    17 Dec 2025
    Share Share
    Sagent Announces Launch of Travoprost Ophthalmic Solution, USP
    Sagent Announces Launch of Travoprost Ophthalmic Solution, USP

    15 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sagent-announces-launch-of-travoprost-ophthalmic-solution-usp-302555682.html

    PR NEWSWIRE
    15 Sep 2025
    Share Share
    Glenmark Pharma arm launches Travoprost Ophthalmic Solution in US
    Glenmark Pharma arm launches Travoprost Ophthalmic Solution in US

    27 Nov 2024

    // BUSINESS STD

    https://www.business-standard.com/markets/capital-market-news/glenmark-pharma-arm-launches-travoprost-ophthalmic-solution-in-u-s-market-124112700214_1.html

    BUSINESS STD
    27 Nov 2024
    Share Share
    Somerset`s Generics Travoprost Receives Approval in US
    Somerset`s Generics Travoprost Receives Approval in US

    23 Sep 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217228

    FDA
    23 Sep 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.